Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Understanding retirement savings in your 50s is vital for effective planning. Learn key strategies to prepare for a secure retirement.
18,168 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
The idea of a bargain in the cruise sector is enticing, but cheap can be risky. This article breaks down how to judge...
Chainlink stands out in crypto as an oracle network that delivers real-world data to smart contracts. This article sh...
SpaceX's IPO hype is hard to ignore, but there are four solid concerns investors should weigh before buying in. This ...
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...
Investors are weighing a mid-year drop in Booking Holdings against solid fundamentals. This guide explains how to ass...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
A billionaire places a bold personal bet on a private space company. This article breaks down what that move means fo...
A bold move from a top capital allocator signals a value tilt even in growth-beat markets. Explore Ackman’s strategy,...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
As investors prepare for Personalis (PSNL) 2025 earnings, this guide breaks down what to watch, how to interpret the ...